Literature DB >> 17015678

Cutting edge: inhibition of T cell activation by TIM-2.

Jared E Knickelbein1, Anjali J de Souza, Richard Tosti, Preeti Narayan, Lawrence P Kane.   

Abstract

T cell Ig and mucin domain protein 2 (TIM-2) has been shown to regulate T cell activation in vitro and T cell-mediated disease in vivo. However, it is still not clear whether TIM-2 acts mainly to augment T cell function or to inhibit it. We have directly examined the function of TIM-2 in murine and human T cell lines. Our results indicate that expression of TIM-2 significantly impairs the induction of NFAT and AP-1 transcriptional reporters by not only TCR ligation but also by the pharmacological stimuli PMA and ionomycin. This does not appear to be due to a general effect on cell viability, and the block in NFAT activation can be bypassed by expression of activated alleles of Ras or calcineurin, or MEK kinase, in the case of AP-1. Thus, our data are consistent with a model whereby TIM-2 inhibits T cell activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015678     DOI: 10.4049/jimmunol.177.8.4966

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.

Authors:  Gordon J Freeman; Jose M Casasnovas; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis.

Authors:  P Ruscitti; F Ciccia; P Cipriani; G Guggino; P Di Benedetto; A Rizzo; V Liakouli; O Berardicurti; F Carubbi; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2015-12-08       Impact factor: 4.330

Review 3.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

4.  TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells.

Authors:  Lee A Albacker; Piia Karisola; Ya-Jen Chang; Sarah E Umetsu; Meixia Zhou; Omid Akbari; Norimoto Kobayashi; Nicole Baumgarth; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

Review 5.  Immune regulation by the TIM gene family.

Authors:  Anjali J de Souza; Lawrence P Kane
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  Biology and function of neuroimmune semaphorins 4A and 4D.

Authors:  EusebiusHenry Nkyimbeng-Takwi; Svetlana P Chapoval
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

Review 7.  The impact of the TIM gene family on tumor immunity and immunosuppression.

Authors:  Muhammad Baghdadi; Masahisa Jinushi
Journal:  Cell Mol Immunol       Date:  2013-12-16       Impact factor: 11.530

8.  Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways.

Authors:  Judong Lee; Ee Wern Su; Chen Zhu; Sarah Hainline; Jiayao Phuah; Jamie A Moroco; Thomas E Smithgall; Vijay K Kuchroo; Lawrence P Kane
Journal:  Mol Cell Biol       Date:  2011-08-01       Impact factor: 4.272

9.  TIM-4 expressed on APCs induces T cell expansion and survival.

Authors:  Roselynn Rodriguez-Manzanet; Jennifer Hartt Meyers; Savithri Balasubramanian; Jacqueline Slavik; Nasim Kassam; Valerie Dardalhon; Edward A Greenfield; Ana C Anderson; Raymond A Sobel; David A Hafler; Terry B Strom; Vijay K Kuchroo
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 10.  The costimulatory role of TIM molecules.

Authors:  Roselynn Rodriguez-Manzanet; Rosemarie DeKruyff; Vijay K Kuchroo; Dale T Umetsu
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.